Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Depreciation & Amortization (CF) (2016 - 2026)

Rockwell Medical filings provide 16 years of Depreciation & Amortization (CF) readings, the most recent being $546000.0 for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 0.55% to $546000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.2 million, a 0.55% increase, with the full-year FY2025 number at $2.2 million, up 0.55% from a year prior.
  • Depreciation & Amortization (CF) hit $546000.0 in Q4 2025 for Rockwell Medical, roughly flat from $544000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $564000.0 in Q3 2023 to a low of $133000.0 in Q4 2021.
  • Median Depreciation & Amortization (CF) over the past 5 years was $370500.0 (2021), compared with a mean of $353000.0.
  • Biggest five-year swings in Depreciation & Amortization (CF): crashed 39.55% in 2021 and later skyrocketed 294.41% in 2023.
  • Rockwell Medical's Depreciation & Amortization (CF) stood at $133000.0 in 2021, then rose by 15.79% to $154000.0 in 2022, then surged by 257.14% to $550000.0 in 2023, then fell by 1.27% to $543000.0 in 2024, then rose by 0.55% to $546000.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $546000.0 (Q4 2025), $544000.0 (Q3 2025), and $563000.0 (Q2 2025) per Business Quant data.